drugset / Trial / NCT01050452

Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

NCT01050452

RandomizedParallel-groupDouble-blindTreatment

Summary

This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.

Timeline

Start
2007-10
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albendazole Small molecule 400 mg
Comparator Ivermectin Small molecule 200 ug/kg
Comparator Mebendazole Small molecule 500 mg